Literature DB >> 7769131

Nonadrenal epinephrine-forming enzymes in humans. Characteristics, distribution, regulation, and relationship to epinephrine levels.

B Kennedy1, T D Bigby, M G Ziegler.   

Abstract

Animal studies indicate that nonadrenal tissues may synthesize epinephrine (E). Here we demonstrate phenylethanolamine N-methyltransferase (PNMT) and/or nonspecific N-methyltransferase (NMT) enzymatic activity in human lung, kidney, heart, liver, spleen, and pancreas. There was a significant overall correlation (r = 0.34) between tissue PNMT and E. PNMT and NMT in human tissues differed in substrate and inhibitor specificity, thermal stability, and antigenicity. By these criteria, PNMT in human lung and in human bronchial epithelial cells were indistinguishable from adrenal PNMT. PNMT and/or NMT activity were present in red blood cells (RBCs), and cancer cell lines. Human kidney, lung, and pancreas showed immunohistochemical staining with an antibody to adrenal PNMT. RBC PNMT activity was lower in males than females and was increased in hyperthyroidism and decreased in hypothyroidism. PNMT activity in a human bronchial epithelial cell line was dramatically increased by incubation with dexamethasone. E and 3H-E levels in plasma and urine during an intravenous infusion of 3H-E into humans indicated that kidney may synthesize half of urinary E. We conclude that PNMT and NMT are widely distributed in human tissues, that they may synthesize E in vivo and are influenced by glucocorticoid and thyroid hormones.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769131      PMCID: PMC295977          DOI: 10.1172/JCI117996

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Influence of beta 1- versus beta 2-adrenoceptor blockade on left ventricular function in humans.

Authors:  L Vanhees; A Aubert; R Fagard; P Hespel; A Amery
Journal:  J Cardiovasc Pharmacol       Date:  1986 Sep-Oct       Impact factor: 3.105

2.  Inhibition of rat kidney histamine-N-methyltransferase by biogenic amines.

Authors:  N Fuhr; E Kownatzki
Journal:  Pharmacology       Date:  1986       Impact factor: 2.547

3.  Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on blood pressure in hypertensive patients known to respond to beta 1-adrenoceptor antagonists.

Authors:  O J Robb; J Webster; J C Petrie; J D Harry; J Young
Journal:  Br J Clin Pharmacol       Date:  1988-04       Impact factor: 4.335

4.  A sensitive radioenzymatic assay for epinephrine forming enzymes.

Authors:  M G Ziegler; B Kennedy; H Elayan
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

5.  Adrenaline and nocturnal asthma.

Authors:  J F Morrison; C Teale; S B Pearson; P Marshall; N M Dwyer; S Jones; H G Dean
Journal:  BMJ       Date:  1990-09-08

6.  Lung epinephrine synthesis.

Authors:  B Kennedy; H Elayan; M G Ziegler
Journal:  Am J Physiol       Date:  1990-04

7.  Molecular cloning of cDNA and chromosomal assignment of the gene for human phenylethanolamine N-methyltransferase, the enzyme for epinephrine biosynthesis.

Authors:  N Kaneda; H Ichinose; K Kobayashi; K Oka; F Kishi; A Nakazawa; Y Kurosawa; K Fujita; T Nagatsu
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

8.  Extraadrenal adrenaline formation by two separate enzymes.

Authors:  M G Ziegler; B Kennedy; H Elayan
Journal:  Experientia       Date:  1989-08-15

9.  Biochemical studies of N-methyltransferase in human and guinea-pig lung: no apparent role in the pathogenesis of asthma.

Authors:  G D Henderson; R E Ruffin; J H Alpers; A J Crockett; D A Schembri; K M Latimer
Journal:  Clin Sci (Lond)       Date:  1988-07       Impact factor: 6.124

10.  Rat renal epinephrine synthesis.

Authors:  M G Ziegler; B Kennedy; H Elayan
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

View more
  14 in total

1.  Genetic regulation of catecholamine synthesis, storage and secretion in the spontaneously hypertensive rat.

Authors:  M L Jirout; R S Friese; N R Mahapatra; M Mahata; L Taupenot; S K Mahata; V Kren; V Zídek; J Fischer; H Maatz; M G Ziegler; M Pravenec; N Hubner; T J Aitman; N J Schork; D T O'Connor
Journal:  Hum Mol Genet       Date:  2010-04-08       Impact factor: 6.150

2.  Endogenous epinephrine protects against obesity induced insulin resistance.

Authors:  Michael G Ziegler; Milos Milic; Ping Sun; Chih-Min Tang; Hamzeh Elayan; Xuping Bao; Wai Wilson Cheung; Daniel T O'Connor
Journal:  Auton Neurosci       Date:  2011-02-26       Impact factor: 3.145

Review 3.  Therapeutic potential of Pnmt+ primer cells for neuro/myocardial regeneration.

Authors:  Aaron Owji; Namita Varudkar; Steven N Ebert
Journal:  Am J Stem Cells       Date:  2013-12-22

Review 4.  Epinephrine and the metabolic syndrome.

Authors:  Michael G Ziegler; Hamzeh Elayan; Milos Milic; Ping Sun; Munir Gharaibeh
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

5.  Gene expression of phenylethanolamine N-methyltransferase in corticotropin-releasing hormone knockout mice during stress exposure.

Authors:  R Kvetnansky; L Kubovcakova; A Tillinger; L Micutkova; O Krizanova; E L Sabban
Journal:  Cell Mol Neurobiol       Date:  2006-05-12       Impact factor: 5.046

6.  Physiological and genomic consequences of adrenergic deficiency during embryonic/fetal development in mice: impact on retinoic acid metabolism.

Authors:  Kingsley Osuala; Candice N Baker; Ha-Long Nguyen; Celines Martinez; David Weinshenker; Steven N Ebert
Journal:  Physiol Genomics       Date:  2012-08-21       Impact factor: 3.107

7.  Distinctive left-sided distribution of adrenergic-derived cells in the adult mouse heart.

Authors:  Kingsley Osuala; Kathleen Telusma; Saad M Khan; Shandong Wu; Mubarak Shah; Candice Baker; Sabikha Alam; Ibrahim Abukenda; Aura Fuentes; Hani B Seifein; Steven N Ebert
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

Review 8.  Intricacies of the Molecular Machinery of Catecholamine Biosynthesis and Secretion by Chromaffin Cells of the Normal Adrenal Medulla and in Pheochromocytoma and Paraganglioma.

Authors:  Annika M A Berends; Graeme Eisenhofer; Lauren Fishbein; Anouk N A V D Horst-Schrivers; Ido P Kema; Thera P Links; Jacques W M Lenders; Michiel N Kerstens
Journal:  Cancers (Basel)       Date:  2019-08-06       Impact factor: 6.639

9.  Structure-Based Drug Design of Bisubstrate Inhibitors of Phenylethanolamine N-Methyltransferase Possessing Low Nanomolar Affinity at Both Substrate Binding Domains1.

Authors:  Jian Lu; Aaron G Bart; Qian Wu; Kevin R Criscione; Michael J McLeish; Emily E Scott; Gary L Grunewald
Journal:  J Med Chem       Date:  2020-11-04       Impact factor: 8.039

10.  Phenylethanolamine N-methyltransferase downregulation is associated with malignant pheochromocytoma/paraganglioma.

Authors:  Seung Eun Lee; Ensel Oh; Boram Lee; Yu Jin Kim; Doo-Yi Oh; Kyungsoo Jung; Jong-Sun Choi; Junghan Kim; Sung Joo Kim; Jung Wook Yang; Jungsuk An; Young Lyun Oh; Yoon La Choi
Journal:  Oncotarget       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.